MARC HOROWITZ to Neoplasms
This is a "connection" page, showing publications MARC HOROWITZ has written about Neoplasms.
Connection Strength
0.124
-
Childhood cancer survivor care: development of the Passport for Care. Nat Rev Clin Oncol. 2014 12; 11(12):740-50.
Score: 0.077
-
Clinician perceptions of Passport for Care, a web-based clinical decision support tool for survivorship care plan delivery. Pediatr Blood Cancer. 2023 01; 70(1):e30070.
Score: 0.033
-
Expression of the cholecystokinin gene in pediatric tumors. Proc Natl Acad Sci U S A. 1992 Jul 01; 89(13):5819-23.
Score: 0.004
-
Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988. Semin Oncol. 1989 Feb; 16(1 Suppl 3):51-5.
Score: 0.003
-
Phase II trial of ifosfamide in children with malignant solid tumors. Cancer Treat Rep. 1987 Feb; 71(2):131-5.
Score: 0.003
-
Chromosome 1 abnormalities: a common feature of pediatric solid tumors. J Natl Cancer Inst. 1985 Jul; 75(1):51-4.
Score: 0.003
-
Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy. Cancer Res. 1987 Mar 01; 47(5):1457-60.
Score: 0.001
-
Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity. Cancer Chemother Pharmacol. 1987; 19(1):57-60.
Score: 0.001